ZellBios
Objective
Invest in a leading player within the space of specialty, high value-added active pharmaceutical ingredients, characterized by favorable market conditions (unlocking robust growth over the medium term) and strong barriers to entry (including access to raw material, handling precautions, complex synthesis protocols, regulatory barriers). Support growth at both organic (through the expansion of the production and industrial sites) and M&A level (through strategic and synergetic add-on acquisitions), while leveraging on a strong reputation, undisputed know-how and development capabilities, as well as a predictable business with good visibility on future cash flows.
Objective
Invest in a leading player within the space of specialty, high value-added active pharmaceutical ingredients, characterized by favorable market conditions (unlocking robust growth over the medium term) and strong barriers to entry (including access to raw material, handling precautions, complex synthesis protocols, regulatory barriers). Support growth at both organic (through the expansion of the production and industrial sites) and M&A level (through strategic and synergetic add-on acquisitions), while leveraging on a strong reputation, undisputed know-how and development capabilities, as well as a predictable business with good visibility on future cash flows.
ENTRY & EXIT
COUNTRY
SECTOR
EMPLOYEES
EMPLOYEES
OVERVIEW
Formed in 2011 through the combination of Farmabios (Italy; acquired in 2007) with Pharmazell (Germany; acquired in 2011)
ZellBios is an independent manufacturer of specialty, high value-added active pharmaceutical ingredients (“APIs”). The company is headquartered in Raubling (Germany) and has production and R&D facilities in Germany, Italy, India, and Switzerland.
OVERVIEW
Formed in 2011 through the combination of Farmabios (Italy; acquired in 2007) with Pharmazell (Germany; acquired in 2011)
ZellBios is an independent manufacturer of specialty, high value-added active pharmaceutical ingredients (“APIs”). The company is headquartered in Raubling (Germany) and has production and R&D facilities in Germany, Italy, India, and Switzerland.
Key Indicators
90%
Key Indicators
#1
~20%
90
Case Studies